The role of sex hormones in women with multiple sclerosis: From puberty to assisted reproductive techniques

Front Neuroendocrinol. 2021 Jan:60:100889. doi: 10.1016/j.yfrne.2020.100889. Epub 2020 Nov 12.

Abstract

Background: Multiple Sclerosis is a multifactorial chronic autoimmune disease, affecting predominantly females in the fertile age. Sex hormones changes during a woman's life, from puberty to menopause, including pregnancy and puerperium, may influence the onset and course of Multiple Sclerosis. The effect of estrogen levels on immune, clinical and radiological aspects of Multiple Sclerosis, also stimulated investigation on the effect of sexual hormones therapies, such as oral contraceptives and assisted reproductive technique, on the Multiple Sclerosis course.

Search strategy and selection criteria: A literature search for original articles and reviews was conducted in the databases, including PubMed, Scopus, and ClinicalTrials.gov of the U.S. National Library of Medicine site from 1988 to 2020.

Results and conclusion: This review reports the effects of the physiological and iatrogenic hormonal changes either on immune or clinical or paraclinical features in the different life stages of women affected by Multiple Sclerosis.

Keywords: Assisted reproductive technique; Estrogens; Multiple sclerosis; Oral contraceptive; Pregnancy.

Publication types

  • Review

MeSH terms

  • Female
  • Gonadal Steroid Hormones
  • Humans
  • Menopause
  • Multiple Sclerosis*
  • Pregnancy
  • Puberty
  • Reproductive Techniques, Assisted

Substances

  • Gonadal Steroid Hormones